Atlas Energy Corp reports financial results and corporate updates as an international upstream royalty and streaming company. The company focuses on the acquisition, management, and monetization of diversified oil and gas royalty and streaming interests across global markets. Its news also covers capital-structure actions and listing status, including its completed recapitalization, TSX Venture Exchange trading under ATLE, voluntary OTCQB delisting, and continued U.S. OTC Pink trading under CANSF.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Willow Biosciences Inc. (OTCQB: CANSF) has announced a commercial agreement with Sandhill One, LLC, following successful development of their BioOxi™ bio-oxidation platform for ursodeoxycholic acid (UDCA). This bioactive compound is essential in treating cholestatic liver disease and gallstone conditions. The innovative collaboration aims to provide a more sustainable, cost-effective production method for UDCA, eliminating reliance on animal-sourced materials. Willow anticipates receiving a significant percentage of Sandhill’s end-market revenues, enhancing potential royalty income. The agreement underscores Willow's commitment to expanding company growth and achieving targeted milestones for 2023.